Stock Events

Stock Events

Aligos Therapeutics (ALGS) Q1 2025 Earnings

10MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-13.08

-8.47

-3.86

0.75

Details

Expected EPS

-2.496667

Actual EPS

-13.08

Surprise EPS

-10.58

Surprise Percent

+423.9%

Description

Aligos Therapeutics (ALGS) has reported earnings of -13.08 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.